```html

Keratitis Sicca (Sjogren’s Syndrome)

What is Keratitis Sicca (Sjogren’s Syndrome)?

Keratitis sicca, commonly known as “dry eye disease,” is a chronic inflammatory condition of the ocular surface that results from insufficient tear production or poor tear quality. When keratitis sicca occurs as part of the systemic autoimmune disorder Sjögren’s syndrome, it reflects the body’s misguided immune attack on the glands that produce tears (lacrimal glands) and saliva. The term keratitis sicca literally means “dry inflammation of the cornea.”

Patients with Sjögren’s‑related dry eye often experience a gritty, burning sensation, blurred vision, and an increased risk of corneal abrasions or infections. Because the eyes are exposed and under‑lubricated, the protective epithelial layer of the cornea becomes vulnerable, leading to chronic discomfort and, in severe cases, visual impairment.

Common Causes

While Sjögren’s syndrome is the most frequent systemic cause of keratitis sicca, many other conditions can produce or aggravate dry eye. Below are ten of the most common contributors:

• Primary Sjögren’s syndrome – Autoimmune destruction of lacrimal and salivary glands.
• Secondary Sjögren’s syndrome – Occurs alongside other autoimmune diseases such as rheumatoid arthritis or systemic lupus erythematosus.
• Age‑related tear film changes – Tear production declines after age 50, especially in post‑menopausal women.
• Medications – Antihistamines, decongestants, antidepressants, beta‑blockers, and isotretinoin can reduce tear secretion.
• Meibomian gland dysfunction (MGD) – Abnormal oil secretion leads to rapid evaporation of tears.
• Contact lens wear – Long‑term use can disrupt the tear layer and cause mechanical irritation.
• Environmental factors – Low humidity, wind, air conditioning, and smoke increase tear evaporation.
• Refractive surgery – LASIK or PRK may temporarily impair corneal nerves that stimulate tear production.
• Viral infections – Chronic infections such as hepatitis C or HIV are linked with secondary Sjögren’s.
• Radiation therapy – Head and neck radiation can damage lacrimal glands.

Associated Symptoms

Dry eye rarely occurs in isolation. The following signs and symptoms often coexist with keratitis sicca, especially when it is part of Sjögren’s syndrome:

• Persistent eye burning, itching, or a feeling of sand in the eye.
• Redness and mild swelling of the conjunctiva.
• Fluctuating or blurred vision that improves with blinking.
• Excessive tearing (reflex tearing) – the eye over‑produces watery tears in response to irritation.
• Sensitivity to light (photophobia).
• Difficulty wearing contact lenses.
• Dry mouth (xerostomia), difficulty swallowing dry foods, or swollen salivary glands.
• Joint pain, stiffness, or swelling (common in systemic autoimmune disease).
• Fatigue, low‑grade fever, and unexplained weight loss.
• Skin rashes or swelling of the lungs, kidneys, or nerves in more severe systemic Sjögren’s.

When to See a Doctor

Most people with mild dryness can improve symptoms with over‑the‑counter lubricants, but certain warning signs warrant prompt professional evaluation:

• Symptoms persisting >3 months despite regular artificial tear use.
• Sudden worsening of vision or prolonged blurry vision.
• Frequent eye “sticking” or crusting, especially upon waking.
• Recurrent eye infections (conjunctivitis or keratitis).
• Noticeable damage to the cornea (white spots, ulceration, or persistent redness).
• Associated systemic problems such as chronic dry mouth, swollen salivary glands, or joint pain.
• Any new medication that could affect tear production, especially if symptoms appear shortly after starting it.

Early evaluation is crucial because untreated keratitis sicca can lead to corneal scarring and permanent visual loss.

Diagnosis

Diagnosing keratitis sicca involves a combination of patient history, clinical examination, and targeted tests to assess tear quantity, quality, and ocular surface health.

1. Clinical History & Symptom Scores

• Ocular Surface Disease Index (OSDI) – A questionnaire that quantifies symptom severity.
• Detailed medication review and assessment for systemic autoimmune disease.

2. Objective Tests

• Schirmer I test – Filter paper placed under the lower eyelid for 5 minutes; <5 mm wetting suggests aqueous‑deficient dry eye.
• Tear Break‑Up Time (TBUT) – Fluorescein dye is applied; time <10 seconds indicates unstable tear film.
• Lissamine green or rose bengal staining – Highlights damaged epithelial cells on the conjunctiva and cornea.
• Meibography – Imaging of the meibomian glands to detect obstruction or atrophy.
• Osmolarity testing – Elevated tear osmolarity (>308 mOsm/L) is a hallmark of dry eye.

3. Laboratory Evaluation (when Sjögren’s is suspected)

• Autoantibody panels: anti‑SSA/Ro and anti‑SSB/La antibodies.
• ANA, rheumatoid factor, and ESR/CRP to assess systemic autoimmune activity.
• Salivary gland biopsy (minor lip biopsy) if diagnosis remains uncertain.

4. Imaging & Ancillary Studies

• Ultrasound or MRI of the lacrimal glands if a structural abnormality is suspected.
• Corneal topography for patients with significant visual fluctuation.

Treatment Options

Treatment is individualized based on severity, underlying cause, and patient preference. The goals are to restore a stable tear film, reduce inflammation, protect the cornea, and improve quality of life.

1. Lubrication & Tear Conservation

• Artificial tears – Preservative‑free drops are preferred for frequent use (e.g., Refresh Optive, Systane Ultra).
• Ointments or gels – Useful at night for prolonged lubrication (e.g., Lacripep, Refresh Nighttime Gel).
• Lipids‑containing drops – Address evaporative dry eye (e.g., Refresh Lipid, Systane Balance).

2. Anti‑Inflammatory Therapies

• Topical cyclosporine 0.05% (Restasis) – Improves tear production by modulating local immune response.
• Topical lifitegrast 5% (Xiidra) – Reduces ocular surface inflammation; rapid symptom relief for many patients.
• Short‑course corticosteroid eye drops – For acute flares; limit use to <2‑4 weeks to avoid cataract or glaucoma.
• Oral tetracycline or doxycycline – Anti‑matrix‑metalloproteinase effect; useful in meibomian gland dysfunction.

3. Punctal Occlusion

Temporary or permanent blockage of the lacrimal puncta (using silicone plugs) reduces tear drainage, allowing tears to remain on the ocular surface longer.

4. Environmental & Behavioral Modifications

• Use a humidifier (30‑40% humidity) in dry indoor environments.
• Take regular “blink breaks” during screen use – 20 seconds of blinking every 20 minutes (the 20‑20‑20 rule).
• Avoid direct airflow from fans, air conditioners, or heating vents.
• Wear wrap‑around glasses or goggles outdoors to limit wind exposure.

5. Systemic Management for Sjögren’s Syndrome

• Hydroxychloroquine or methotrexate for systemic autoimmune control (prescribed by a rheumatologist).
• Pilocarpine or cevimeline – Oral secretagogues that stimulate salivary and lacrimal flow.
• Biologic agents (e.g., rituximab) in refractory cases, under specialist supervision.

6. Advanced Therapies (for refractory disease)

• Autologous serum eye drops – Contain growth factors and vitamins; prepared from the patient’s own blood.
• Amniotic membrane transplantation – Provides a biologic bandage for severe corneal epithelial defects.
• Intense pulsed light (IPL) therapy – Targets meibomian gland obstruction and reduces inflammation.

Prevention Tips

While Sjögren’s syndrome cannot be prevented, many modifiable factors can lessen the frequency and severity of keratitis sicca episodes:

• Stay well‑hydrated; aim for at least 8 cups of water daily.
• Limit caffeine and alcohol, which can have a mild diuretic effect.
• Take breaks during prolonged visual tasks—blink consciously.
• Choose preservative‑free eye drops if you need frequent lubrication.
• Monitor medication side‑effects; discuss alternatives with your prescriber if you notice dry eyes.
• Wear protective eyewear in windy, dusty, or smoky environments.
• Maintain a balanced diet rich in omega‑3 fatty acids (fish, flaxseed, walnuts); evidence suggests they improve tear quality.
• Manage systemic autoimmune disease with regular rheumatology follow‑up to keep inflammation under control.

Emergency Warning Signs

---

Key Takeaways

• Keratitis sicca (dry eye) is a common manifestation of Sjögren’s syndrome but can also result from many other local or systemic factors.
• Early recognition, proper testing, and a stepwise treatment plan can preserve vision and markedly improve comfort.
• Patients should be educated on the importance of regular eye‑drop use, environmental control, and prompt reporting of worsening symptoms.
• Collaboration between ophthalmologists, rheumatologists, and primary‑care physicians ensures comprehensive management of the underlying autoimmune disease.

For more detailed information, consult reputable sources such as the Mayo Clinic, the American Academy of Ophthalmology, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and peer‑reviewed ophthalmology journals.

```